Health Canada Gives Green Light to Moderna’s New Influenza Vaccines
Health Canada has authorized two new mRNA vaccines developed by Moderna to help protect adults against seasonal influenza and COVID-19. The approvals, announced on November 5, 2026, cover an updated influenza vaccine called mFLUSIVA and a combination influenza and COVID-19 vaccine called mCOFLU. Both vaccines are authorized for adults aged 50 and older. The announcement … Read more